View in EDS

Survival after intensive therapy or clofarabine in fit older adults with acute myeloid leukemia: E2906 phase 3 trial.

Saved in:
Bibliographic Details
Title: Survival after intensive therapy or clofarabine in fit older adults with acute myeloid leukemia: E2906 phase 3 trial.
Authors: Foran JM; Division of Hematology and Medical Oncology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville, FL., Sun Z; ECOG-ACRIN Biostatistics Center, Dana-Farber Cancer Institute, Brookline, MA., Luger SM; Division of Hematology-Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Claxton DF; Penn State Cancer Institute, Penn State Milton S. Hershey Medical Center, Hershey, PA., Lazarus HM; Department of Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH., Arber DA; Department of Pathology, University of Chicago, Chicago, IL., Rowe JM; Shaare Zedek Medical Center, Jerusalem, Israel., Paietta E; ECOG-ACRIN Leukemia Translational Laboratory, Montefiore Medical Center, Bronx, NY., Racevskis J; ECOG-ACRIN Leukemia Translational Laboratory, Montefiore Medical Center, Bronx, NY., Garrett-Bakelman F; Division of Hematology and Medical Oncology, Department of Medicine, University of Virginia Cancer Center, Charlottesville, VA., Zhang Y; Memorial Sloan Kettering Cancer Center, New York, NY., Altman JK; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Al-Kali A; Division of Hematology, Mayo Clinic, Rochester, MN., Zheng H; Penn State Cancer Institute, Penn State Milton S. Hershey Medical Center, Hershey, PA., Pratz KW; Sidney Kimmel Cancer Center. Johns Hopkins University, Baltimore, MD., Broun ER; The Jewish Hospital, Cincinnati, OH., Powell BL; Department of Cancer Medicine, Wake Forest University School of Medicine, Winston-Salem, NC., O'Dwyer KM; Division of Hematology and Oncology, Department of Medicine, University of Rochester School of Medicine, Rochester, NY., Godwin JE; Providence Portland Medical Center, Portland, OR., Ofran Y; Shaare Zedek Medical Center, Jerusalem, Israel., Litzow MR; Division of Hematology, Mayo Clinic, Rochester, MN., Tallman MS; Memorial Sloan Kettering Cancer Center, New York, NY.
Source: Blood neoplasia [Blood Neoplasia] 2026 Jan 14; Vol. 3 (2), pp. 100194. Date of Electronic Publication: 2026 Jan 14 (Print Publication: 2026).
Publication Type: Clinical Trial; Journal Article
Journal Info: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918841988906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-3280 (Electronic) Linking ISSN: 29503280 NLM ISO Abbreviation: Blood Neoplasia Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41890705
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Survival after intensive therapy or clofarabine in fit older adults with acute myeloid leukemia: E2906 phase 3 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Foran+JM%22">Foran JM</searchLink>; Division of Hematology and Medical Oncology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville, FL.<br /><searchLink fieldCode="AU" term="%22Sun+Z%22">Sun Z</searchLink>; ECOG-ACRIN Biostatistics Center, Dana-Farber Cancer Institute, Brookline, MA.<br /><searchLink fieldCode="AU" term="%22Luger+SM%22">Luger SM</searchLink>; Division of Hematology-Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Claxton+DF%22">Claxton DF</searchLink>; Penn State Cancer Institute, Penn State Milton S. Hershey Medical Center, Hershey, PA.<br /><searchLink fieldCode="AU" term="%22Lazarus+HM%22">Lazarus HM</searchLink>; Department of Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH.<br /><searchLink fieldCode="AU" term="%22Arber+DA%22">Arber DA</searchLink>; Department of Pathology, University of Chicago, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Rowe+JM%22">Rowe JM</searchLink>; Shaare Zedek Medical Center, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Paietta+E%22">Paietta E</searchLink>; ECOG-ACRIN Leukemia Translational Laboratory, Montefiore Medical Center, Bronx, NY.<br /><searchLink fieldCode="AU" term="%22Racevskis+J%22">Racevskis J</searchLink>; ECOG-ACRIN Leukemia Translational Laboratory, Montefiore Medical Center, Bronx, NY.<br /><searchLink fieldCode="AU" term="%22Garrett-Bakelman+F%22">Garrett-Bakelman F</searchLink>; Division of Hematology and Medical Oncology, Department of Medicine, University of Virginia Cancer Center, Charlottesville, VA.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Altman+JK%22">Altman JK</searchLink>; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Al-Kali+A%22">Al-Kali A</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Zheng+H%22">Zheng H</searchLink>; Penn State Cancer Institute, Penn State Milton S. Hershey Medical Center, Hershey, PA.<br /><searchLink fieldCode="AU" term="%22Pratz+KW%22">Pratz KW</searchLink>; Sidney Kimmel Cancer Center. Johns Hopkins University, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22Broun+ER%22">Broun ER</searchLink>; The Jewish Hospital, Cincinnati, OH.<br /><searchLink fieldCode="AU" term="%22Powell+BL%22">Powell BL</searchLink>; Department of Cancer Medicine, Wake Forest University School of Medicine, Winston-Salem, NC.<br /><searchLink fieldCode="AU" term="%22O'Dwyer+KM%22">O'Dwyer KM</searchLink>; Division of Hematology and Oncology, Department of Medicine, University of Rochester School of Medicine, Rochester, NY.<br /><searchLink fieldCode="AU" term="%22Godwin+JE%22">Godwin JE</searchLink>; Providence Portland Medical Center, Portland, OR.<br /><searchLink fieldCode="AU" term="%22Ofran+Y%22">Ofran Y</searchLink>; Shaare Zedek Medical Center, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Litzow+MR%22">Litzow MR</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Tallman+MS%22">Tallman MS</searchLink>; Memorial Sloan Kettering Cancer Center, New York, NY.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918841988906676%22">Blood neoplasia</searchLink> [Blood Neoplasia] 2026 Jan 14; Vol. 3 (2), pp. 100194. <i>Date of Electronic Publication: </i>2026 Jan 14 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%2C+Inc%22">Elsevier, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918841988906676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2950-3280 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2229503280%22">29503280 </searchLink><i>NLM ISO Abbreviation: </i>Blood Neoplasia <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41890705
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.bneo.2026.100194
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100194
    Titles:
      – TitleFull: Survival after intensive therapy or clofarabine in fit older adults with acute myeloid leukemia: E2906 phase 3 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Foran JM
      – PersonEntity:
          Name:
            NameFull: Sun Z
      – PersonEntity:
          Name:
            NameFull: Luger SM
      – PersonEntity:
          Name:
            NameFull: Claxton DF
      – PersonEntity:
          Name:
            NameFull: Lazarus HM
      – PersonEntity:
          Name:
            NameFull: Arber DA
      – PersonEntity:
          Name:
            NameFull: Rowe JM
      – PersonEntity:
          Name:
            NameFull: Paietta E
      – PersonEntity:
          Name:
            NameFull: Racevskis J
      – PersonEntity:
          Name:
            NameFull: Garrett-Bakelman F
      – PersonEntity:
          Name:
            NameFull: Zhang Y
      – PersonEntity:
          Name:
            NameFull: Altman JK
      – PersonEntity:
          Name:
            NameFull: Al-Kali A
      – PersonEntity:
          Name:
            NameFull: Zheng H
      – PersonEntity:
          Name:
            NameFull: Pratz KW
      – PersonEntity:
          Name:
            NameFull: Broun ER
      – PersonEntity:
          Name:
            NameFull: Powell BL
      – PersonEntity:
          Name:
            NameFull: O'Dwyer KM
      – PersonEntity:
          Name:
            NameFull: Godwin JE
      – PersonEntity:
          Name:
            NameFull: Ofran Y
      – PersonEntity:
          Name:
            NameFull: Litzow MR
      – PersonEntity:
          Name:
            NameFull: Tallman MS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 01
              Text: 2026 Jan 14
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2950-3280
          Numbering:
            – Type: volume
              Value: 3
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Blood neoplasia
              Type: main
ResultId 1